Expression of human NAD(P)H:quinone oxidoreductase (DT-diaphorase) in Chinese hamster ovary cells: Effect on the toxicity of antitumor quinones

Molecular Pharmacology

Volumn 50, Issue 4, 1996, Pages 728-735

  Gustafson, Daniel L ^a,b   Beall, Howard D ^b   Bolton, Emiko M ^b   Ross, David ^b   Waldren, Charles A ^a,b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIAZIRIDINYL 3,6 DIMETHYL 1,4 BENZOQUINONE; 5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE; ANTINEOPLASTIC AGENT; MENADIONE; MITOMYCIN C; QUINONE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); RUFOCROMOMYCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

NON-PROGRAMMATIC;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BIOTRANSFORMATION; CELL SURVIVAL; CHO CELLS; CRICETINAE; CYTOCHROME REDUCTASES; CYTOCHROME-B(5) REDUCTASE; DICUMAROL; DNA, COMPLEMENTARY; ENZYME INHIBITORS; HUMANS; MITOMYCIN; NAD(P)H DEHYDROGENASE (QUINONE); NADPH-FERRIHEMOPROTEIN REDUCTASE; QUINONES; TRANSFECTION; VITAMIN K; XANTHINE DEHYDROGENASE;

EID: 0029860030     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Walton, M. I., P. J. Smith, and P. Workman. The role of NAD(P)H:quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indolquinone antitumor agent EO9. Cancer Commun. 3:199-206 (1991).
2. Siegel, D., N. W. Gibson, P. C. Preusch, and D. Ross. Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 50:7483-7489 (1990).
3. Schlager, J. J., and G. Powis. NAD(P)H:quinone acceptor oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int. J. Cancer 45:403-409 (1990).
4. Koudstaal, J., B. Makkink, and S. H. Overdiep. Enzyme histochemical pattern in human tumours: II. Oxidoreductases in carcinoma of the colon and the breast. Eur. J. Cancer 11:111-115 (1975).
5. Schor, N. A., and C. J. Cornelisse. Biochemical and quantitative histochemical study of reduced pyridine nucleotide dehydrogenation by human colon carcinomas. Cancer Res. 43:4850-4855 (1983).
6. Cresteil, T., and A. K. Jaiswal. High levels of expression of the NAD(P)H: quinone oxidoreductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochem. Pharmacol. 42:1021-1027 (1991).
7. Workman, P., M. I. Walton, G. Powis, and J. J. Schlager. DT-diaphorase: questionable role in mitomycin C resistance, but a target for novel bioreductive drugs. Br. J. Cancer 60:800-802 (1995).
8. Riley, R. J., and P. Workman. DT-diaphorase and cancer chemotherapy. Biochem. Pharmacol. 43:1657-1669 (1992).
9. Keyes, S. R., S. Rockwell, and A. C. Sartorelli. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Cancer Res. 49:3310-3313 (1989).
10. Keyes, S. R., S. Rockwell, and A. C. Sartorelli. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro. Cancer Res. 45:213-216 (1985).
11. Dulhanty, A. M., and G. F. Whitmore. Chinese hamster ovary cell lines resistant to mitomycin C under aerobic but not hypoxic conditions are deficient in DT-diaphorase. Cancer Res. 51:1860-1865 (1995).
12. Malkinson, A. M., D. Siegel, G. L. Forrest, A. F. Gazdar, H. K. Oie, D. C. Chan, P. A. Bunn, M. Mabry, D. J. Dykes, S. D. Harrison Jr., and D. Ross. Elevated DT-diaphorase activity and messenger RNA content in human non-small lung cell carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res. 52:4752-4757 (1992).
13. Ross, D., D. Siegel, H. Beall, A. S. Prakash, R. T. Mulcahy, and N. W. Gibson. DT-diaphorase in activation and detoxification of quinones: bioreductive activation of mitomycin C. Cancer Metastasis Rev. 12:83-101 (1993).
14. Gustafson, D. L., and C. A. Pritsos. Enhancement of xanthine dehydrogenase mediated mitomycin C metabolism by dicumarol. Cancer Res. 52: 6936-6939 (1992).
15. 5 reductase. Cancer Res. 53:4907-4912 (1993).
16. Keyes, S. R., P. M. Fracasso, D. C. Heimbrook, S. Rockwell, S. G. Sligar, and A. C. Sartorelli. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C. Cancer Res. 44:5638-5643 (1984).
17. Siegel, D., H. Beall, C. Senekowitsch, M. Kasai, H. Arai, N. W. Gibson, and D. Ross. Bioreductive activation of mitomycin C by DT-diaphorase. Biochemistry 31:7879-7885 (1992).
18. Pan, S. S., P. A. Andrews, C. J. Glover, and N. R. Bachur. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem. 259:959-966 (1984).
19. Gustafson, D. L., and C. A. Pritsos. Bioactivation of mitomycin C by xanthine dehydrogenase from EMT6 mouse mammary carcinoma tumors. J. Natl. Cancer Inst. 84:1180-1185 (1992).
20. Marshall, R. S., M. C. Paterson, and A. M. Rauth. Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions. Br. J. Cancer 39:341-346 (1989).
21. Robertson, N., I. J. Stratford, S. Houlbrook, J. Carmichael, and G. E. Adams. The sensitivity of human tumour cells to quinone bioreductive drugs: what role for DT-diaphorase? Biochem. Pharmacol. 44:409-412 (1992).
22. Beall, H. D., A. M. Murphy, D. Siegel, R. H. J. Hargreaves, J. Butler, and D. Ross. NAD(P)H quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines. Mol. Pharmacol. 48:499-504 (1995).
23. Paull, K., R. Camalier, S. A. Fitzsimmons, A. D. Lewis, P. Workman, and M. Grever. Correlations of DT-diaphorase expression with cell sensitivity data obtained from the NCI human tumor cell line panel. Proc. Am. Assoc. Cancer Res. 35:369(1994).
24. Hodnick, H. F., M. F. Belcourt, B. Kemple, S. Rockwell, and A. C. Sartorelli. Potentiation of mitomycin C and porfiromycin toxicity to Chinese hamster ovary (CHO) cells by overexpression of DT-diaphorase (DTD) cDNA. Proc. Am. Assoc. Cancer Res. 36:602(1995).
25. Beall, H. D., R. T. Mulcahy, D. Siegel, R. D. Traver, N. W. Gibson, and D. Ross. Metabolism of bioreductive antitumor compounds by purified rat and human DT-diaphorase. Cancer Res. 54:3196-3201 (1994).
26. Boland, M. P., R. J. Knox, and J. J. Roberts. The differences in kinetics of rat and human DT diaphorase result in a differential sensitivity of derived cell lines to CB 1954 (5-(aziridinyl-1-yl)-2,4-dinitrobenzamide). Biochem. Pharmacol. 41:867-875 (1991).
27. Ernster, L. DT-diaphorase. Methods Enzymol 10:309-317 (1967).
28. Benson, A. M., M. J. Hunkler, and P. Talalay. Increase of NAD(P)H: quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. USA 77:5216-5220 (1980).
29. Strobel, H. W., and J. D. Dignam. Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52:89-96 (1978).
30. Stirpe, F., and E. Della Corte. The regulation of rat liver xanthine dehydrogenase: conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J. Biol. Chem. 244:3855-3863 (1969).
31. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63 (1983).
32. Ross, D., H. D. Beall, D. Siegel, R. D. Traver, and D. L. Gustafson. Enzymology of bioreductive drug activation. Br. J. Cancer 74(Suppl. 27): 51-58 (1996).
33. Martins, E. A. L., L. Mori, H. C. Birnboim, and R. Meneghini. Menadione-resistant Chinese hamster cell variants are cross-resistant to hydrogen peroxide and exhibit stable chromosomal and biochemical alterations. Mol. Cell. Biochem. 118:181-189 (1992).
34. Thor, H., M. T. Smith, P. Hartzell, G. Bellomo, S. A. Jewell, and S. Orrenius. The metabolism of menadione (2-methyl-1,4-napthoquinone) by isolated hepatocytes: a study of the implications of oxidative stress in intact cells. J. Biol. Chem. 257:12419-12425 (1982).
35. Doroshow, J. H. Reductive activation of mitomycin C: a delicate balance. J. Natl. Cancer Inst. 84:1138-1139 (1992).
36. Jones, N. J. Genetic analysis of mitomycin C-hyperaensitive Chinese hamster cell mutants. Mutagenesis 9:477-482 (1994).
37. Powis, G., P. Y. Gasdaska, A. Gallegos, K. Sherrill, and D. Goodman. Over-expression of DT-diaphorase in transfected NIH3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs. Anticancer Res. 15:1141-1146 (1995).
38. Fitzsimmons, S. A., P. Workman, M. Grever, K. Paull, and A. D. Lewis. Differential expression of DT-diaphorase, cytochrome P450 reductase and cytochrome b5 reductase in the NCI human tumour cell line panel. Proc. Am. Assoc. Cancer Res. 35:369(1994).
39. Anderson, R. F., K. B. Patel, K. Reghebi, and S. A. Hill. Conversion of xanthine dehydrogenase to xanthine oxidase as a possible marker for hypoxia in tumours and normal tissue. Br. J. Cancer 60:193-197 (1989).
40. Wajner, M., and R. A. Harkness. Distribution of xanthine dehydrogenase and oxidase activities in human and rabbit tissues. Biochim. Biophys. Acta 991:79-84 (1989).